WATS3D for Barrett’s Screening and Surveillance: A New Standard of Care - When and why the technology should be used

October 22, 2020

CDx Diagnostics
Dr. Michael Smith and Dr. Sri Komanduri examine a method of esophageal tissue sampling to assist in the finding of Barrett’s esophagus and cancerous tissue: WATS3D. The panelists review a growing body of clinical evidence for WATS3D and discuss indications for WATS3D among BE surveillance. Learn how to integrate WATS3D & make your next EGD more reliable.
CDX, CDX Diagnostics, VirtualEd, replay, Sri Komanduri, Dr. Sri Komanduri, Dr Sri Komanduri, Dr. Komanduri, Dr Komanduri, Michael Smith, Michael S Smith, Dr. Smith, Dr Smith, Dr. Michael Smith, Dr Michael Smith, WATS3D, BE, barrett’s esophagus, barrett’s esophagus, tissue sampling, EAC, esophageal adenocarcinoma, dysplasia, BE screening, BE surveillance, barrett’s esophagus surveillance, barrett’s esophagus screening, HGD, LGD, NDBE, IM, computer assisted analysis, transepithelial sampling, dysphagia, reflux, WATS3D evidence, WATS3D clinical data, WATS3D data